Ursodeoxycholic acid tablets

This product can increase the secretion of bile acid and cause changes in the composition of bile acid, increasing the content of this product in bile. This product can also significantly reduce the molar concentration of cholesterol and cholesterol esters in human bile and the saturation index of cholesterol, thus facilitating the gradual dissolution of cholesterol in stones.

Ursodeoxycholic acid.

Ursodeoxycholic acid is a white crystalline powder, odorless and bitter. It is almost insoluble in water, easily soluble in ethanol and glacial acetic acid, slightly soluble in imitation, and very slightly soluble in ether. This product is a white tablet.

This product is used for cholesterol gallstone formation and bile-deficient steatorrhea. It can also be used to prevent drug-induced stone formation and treat steatorrhea (after ileal resection).

Adult oral administration: 8-10 mg/kg daily, divided into two doses during the morning and evening meals. The shortest course of treatment is 6 months. If there is no improvement in ultrasound examination and cholecystography after 6 months, the drug can be discontinued; if the stones have partially dissolved, continue to take the drug until the stones are completely dissolved.

The toxicity and side effects of this product are less than those of chenodeoxycholic acid. It generally does not cause diarrhea. Other occasional adverse reactions include constipation, allergies, headache, dizziness, pancreatitis and tachycardia.

It is contraindicated in patients with complete biliary obstruction and severe liver dysfunction.

Precautions for children: Not clear. Precautions for pregnancy and lactation: Contraindicated for pregnant and lactating women. Precautions for the elderly: Use with caution in elderly patients.

1. Contraceptive pills can increase bile saturation. When using this product for treatment, other birth control measures should be taken as much as possible to avoid affecting the efficacy. 2. Cholestyramine (Cholestyramine), colestipol (Colestipol) and aluminum-containing antacids can bind to CDCA and reduce its absorption, so they should not be used together.

Keep away from light and store in sealed container.

50mg

60 months

Panjin Hengchanglong Pharmaceutical Co., Ltd.

• Founded in:

  2002-01-09

• Address:

  Ping'an Township, Dawa County

• Tax NO.:

  91211100734207588A

• Registered Funds:

  60 million yuan

• Website:

  Log in to view

• Email:

  Log in to view